19delL858R?

Seoree Kim1, Yunseok Heo2, Young-Ho Lee2,3,4,5,6

  • 1Division of Medical Hemato-Oncology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.

PubMed
概括

了解像L858R这样的表皮生长因子受体 (EGFR) 突变亚型是关键. 尽管已知分子差异,目前对EGFR突变的治疗策略需要进化以匹配这些独特的生物特征.